Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Clinical trial NCT03762759 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03762759
Sponsor: Emory University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Adenocarcinoma

Start date: 2019-05-10
Primary completion: 2025-05-19
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.